Eisai Co - Company & Market Research Reports

Home /
Companies /
Eisai Co

Eisai Limited is a research-based pharmaceutical company that develops, manufactures, and markets healthcare products for patients and their families. It offers products in the areas of Alzheimer's disease, gastrointestinal disorders, epilepsy, cervical dystonia, severe chronic pain, and oncology. The company was founded in 1988 and is based in Hatfield, United Kingdom. It also has operations in the United States, Asia, and Europe.

REFINE BY

KEYWORD

CATEGORIES

Central Nervous System Drugs 118
Oncology Drugs 114
Drug Discovery 66
Gastrointestinal Drugs 54
Clinical Trials 32
Alzheimer's Disease Drugs 31
Musculoskeletal Disorders Drugs 29
Pharmaceuticals 28
Liver Cancer Drugs 27
Cardiovascular Drugs 21
Brain Cancer Drugs 21
Immune Disorders Drugs 20
Infectious Diseases Drugs 18
Leukemia Drugs 18
Breast Cancer Drugs 17
Biopharmaceuticals 17
Lymphoma Drugs 15
Kidney Cancer Drugs 12
Endocrine and Metabolic Disorders Drugs 12
Drugs by Therapeutic Area 11
Anesthetic Drugs 11
Skin Cancer Drugs 11
Infusions and Injectables 10
Drug Delivery 9
Colon Cancer Drugs 8
Analgesics 8
Hematological Drugs 8
Liver and Kidney Disorders Drugs 8
Thyroid Cancer Drugs 8
Lung Cancer Drugs 7
Uterine Cancer Drugs 7
Anti-Obesity Drugs 7
Pharmaceutical Manufacturing 7
Ovarian Cancer Drugs 6
Bladder Cancer Drugs 6
Over the Counter (OTC) Drugs 6
Vitamins and Dietary Supplements 6
Respiratory Drugs 5
Company Reports 4
Optical Disorders Drugs 4
Mental Disorders Drugs 4
Dermatological Drugs 4
Pharmaceutical Intermediates 3
Cervical Cancer Drugs 3
Prostate Cancer Drugs 2
Biosimilars and Biosuperiors 2
Pancreatic Cancer Drugs 2
Sexual and Reproductive Health Drugs 2
Diabetes Drugs 1
Generic Drugs 1
Pharmacoeconomics 1
Vaccines 1
Psoriasis Drugs 1
Immunosuppressive Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



272 reviews

679 Results (Page 7 of 34)
- Relevance
  Sort by

Bladder Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
November 2022
734 Pages
Global

From

€2304EUR$2,500USD£1,948GBP

Endometrial Cancer Treatment Market Report 2025

 Report
February 2025
200 Pages
Global

From

€4138EUR$4,490USD£3,499GBP

Anti-Migraine Drugs Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

 Report
July 2024
99 Pages
Global

From

€3500EUR$4,068USD£3,063GBP

Sleep Aids Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

 Report
June 2022
120 Pages
Global

From

€4378EUR$4,750USD£3,701GBP

Alzheimer's Therapeutics Market Size, Share & Trends Analysis By Product (Cholinesterase Inhibitors, NMDA Receptor Antagonist, Combination Drug, Pipeline Drugs), By End-user, By Region, And Segment Forecasts, 2023-2030

 Report
June 2023
103 Pages
Global

From

€5483EUR$5,950USD£4,636GBP

NEED HELP FINDING THE RIGHT PRODUCT? Farid will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Ovarian Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
December 2022
1560 Pages
Global

From

€2304EUR$2,500USD£1,948GBP

Endometrial Cancer - Pipeline Insight, 2025

 Clinical Trials
April 2025
180 Pages
Global

From

€2304EUR$2,500USD£1,948GBP

Bile Duct Cancer (Cholangiocarcinoma) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
December 2022
507 Pages
Global

From

€2304EUR$2,500USD£1,948GBP

Alzheimer's Disease Therapeutics Market Forecast - Epidemiology & Pipeline Analysis 2023-2028

 Report
February 2023
244 Pages
Global

From

€3871EUR$4,200USD£3,273GBP

Colorectal Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
December 2022
1588 Pages
Global

From

€2304EUR$2,500USD£1,948GBP

Colon Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
December 2022
746 Pages
Global

From

€2304EUR$2,500USD£1,948GBP

Endometrial Cancer Market - Growth, Trends, and Forecasts (2023 - 2028)

 Report
April 2023
112 Pages
Global

From

€4378EUR$4,750USD£3,701GBP

Lennox-Gastaut Syndrome - Global Clinical Trials Review, 2024

 Clinical Trials
January 2024
176 Pages
Global

From

€2304EUR$2,500USD£1,948GBP

Fallopian Tube Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
August 2022
871 Pages
Global

From

€2304EUR$2,500USD£1,948GBP

United States Endometrial Cancer Market, Competition, Forecast and Opportunities, 2018-2028

 Report
October 2023
90 Pages
United States

From

€3226EUR$3,500USD£2,727GBP

Migraine With Brainstem Aura Drug Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

 Report
April 2023
118 Pages
Global

From

€3500EUR$4,068USD£3,063GBP

Kidney Cancer Drugs Market by Type, Pharmacologic Class, Therapeutic Class - Global Forecast 2025-2030

 Report
October 2024
189 Pages
Global

From

€3267EUR$3,545USD£2,762GBP

€3630EUR$3,939USD£3,069GBP

Alzheimer's Disease Diagnostics & Therapeutics Market by Product (Diagnostics, Therapeutics), Patient Demographics (65-74 Years, 75-84 Years, Above 85 Years), Disease Stage, End User, Distribution Channel - Global Forecast 2025-2030

 Report
March 2025
186 Pages
Global

From

€3267EUR$3,545USD£2,762GBP

€3630EUR$3,939USD£3,069GBP

Hypocobalaminemia (Vitamin B12) Deficiency Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update

 Report
August 2023
81 Pages
Global

From

€2304EUR$2,500USD£1,948GBP

Neurology Clinical Trials Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

 Report
August 2022
118 Pages
Global

From

€4378EUR$4,750USD£3,701GBP

679 Results (Page 7 of 34)
- 1
- 5
- 6
- 7
- 8
- 9

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.